Ads
related to: biotechnology
Search results
Genmab completes $1.8 billion acquisition of ProfoundBio By Investing.com
Investing.com· 12 hours agoGenmab A/S (NASDAQ:GMAB), a biotechnology company specializing in antibody therapeutics, has...
Sana Biotechnology Inc (NASDAQ: SANA) Is Up 111.52% Year-To-Date, But Analysts Find Room For A Price...
Stocks Register· 21 hours agoSana Biotechnology Inc (NASDAQ:SANA) traded at $8.63 at close of the session on Monday, May 20, made a downward move of -1.15% on its previous day’s price. Looking at the ...
Cathie Wood's ARK buys CRSP, sells TDOC stock By Investing.com
Investing.com· 3 hours agoCathie Wood's ARK buys CRSP, sells TDOC stock
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 14 hours agoEli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals...
Anixa advances CAR-T trial for ovarian cancer with fifth patient By Investing.com
Investing.com· 11 hours agoAnixa Biosciences, Inc. (NASDAQ: NASDAQ:ANIX), a clinical-stage biotechnology company, has begun...
All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy
Zacks via Yahoo Finance· 5 days agoUNITY Biotechnology (UBX) might move higher on growing optimism about its earnings prospects, which...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 18 hours agoDive Brief: Biotechnology startup AltruBio on Tuesday raised a Series B round that could hand it up...
Earnings call: BiomX reports Q1 2024 results, optimistic on phage therapies By Investing.com
Investing.com· 12 hours agoBiomX Inc. (NYSE: NYSE:PHGE), a biotechnology company specializing in phage-based therapies, has...
PDS Biotechnology (NASDAQ:PDSB) Rating Reiterated by HC Wainwright
ETF DAILY NEWS· 5 days agoPDS Biotechnology (NASDAQ:PDSB – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Wednesday, Benzinga ...
AltruBio Gathers Funds as Biotechs Aim for Next Blockbuster Anti-Inflammatory Therapy
The Wall Street Journal· 16 hours agoBiotechnology startup AltruBio has secured fresh capital to develop a drug for ulcerative colitis as...